These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27367716)

  • 21. Preparation of vesicular stomatitis virus pseudotype with Chikungunya virus envelope protein.
    Tong W; Yin XX; Lee BJ; Li YG
    Acta Virol; 2015 Jun; 59(2):189-93. PubMed ID: 26104337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes.
    Goo L; Dowd KA; Lin TY; Mascola JR; Graham BS; Ledgerwood JE; Pierson TC
    J Infect Dis; 2016 Nov; 214(10):1487-1491. PubMed ID: 27655868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice.
    Tretyakova I; Hearn J; Wang E; Weaver S; Pushko P
    J Infect Dis; 2014 Jun; 209(12):1882-90. PubMed ID: 24585894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and characterization of a double subgenomic chikungunya virus infectious clone to express heterologous genes in Aedes aegypti mosquitoes.
    Vanlandingham DL; Tsetsarkin K; Hong C; Klingler K; McElroy KL; Lehane MJ; Higgs S
    Insect Biochem Mol Biol; 2005 Oct; 35(10):1162-70. PubMed ID: 16102421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of green fluorescent protein-tagged virus-like particles as a tracer in the early phase of chikungunya infection.
    Tumkosit U; Maeda Y; Kishishita N; Siripanyaphinyo U; Omori H; Chetanachan P; Sittisaman P; Jityam C; Priengprom T; Mizushima H; Wongjaroen P; Mekada E; Tatsumi M; Takeda N; Tanaka A
    Virus Res; 2019 Oct; 272():197732. PubMed ID: 31445103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity.
    Lum FM; Couderc T; Chia BS; Ong RY; Her Z; Chow A; Leo YS; Kam YW; Rénia L; Lecuit M; Ng LFP
    Sci Rep; 2018 Jan; 8(1):1860. PubMed ID: 29382880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visualization of chikungunya virus infection
    Zhang HL; Dong HL; Zhang YN; Xu LL; Deng CL; Li XF; Li XD; Ye HQ; Yuan ZM; Qin CF; Zhang B
    Emerg Microbes Infect; 2019; 8(1):1574-1583. PubMed ID: 31682177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and characterization of a stable eGFP enterovirus 71 for antiviral screening.
    Shang B; Deng C; Ye H; Xu W; Yuan Z; Shi PY; Zhang B
    Antiviral Res; 2013 Feb; 97(2):198-205. PubMed ID: 23267829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection and characterization of protective anti-chikungunya virus single domain antibodies.
    Liu JL; Shriver-Lake LC; Zabetakis D; Anderson GP; Goldman ER
    Mol Immunol; 2019 Jan; 105():190-197. PubMed ID: 30550981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.
    Pohjala L; Utt A; Varjak M; Lulla A; Merits A; Ahola T; Tammela P
    PLoS One; 2011; 6(12):e28923. PubMed ID: 22205980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection.
    Kishishita N; Takeda N; Anuegoonpipat A; Anantapreecha S
    J Clin Microbiol; 2013 May; 51(5):1389-95. PubMed ID: 23408687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of novel antibodies against non-structural proteins nsP1, nsP3 and nsP4 of chikungunya virus: potential use in basic research.
    Kumar S; Mamidi P; Kumar A; Basantray I; Bramha U; Dixit A; Maiti PK; Singh S; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
    Arch Virol; 2015 Nov; 160(11):2749-61. PubMed ID: 26280524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chikungunya-specific IgG and neutralizing antibody responses in natural infection of Chikungunya virus in children from India.
    Verma A; Nayak K; Chandele A; Singla M; Ratageri VH; Lodha R; Kabra SK; Murali-Krishna K; Ray P
    Arch Virol; 2021 Jul; 166(7):1913-1920. PubMed ID: 33907861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of recombinant rabies Virus CVS-11 expressing eGFP applied to the rapid virus neutralization test.
    Xue X; Zheng X; Liang H; Feng N; Zhao Y; Gao Y; Wang H; Yang S; Xia X
    Viruses; 2014 Apr; 6(4):1578-89. PubMed ID: 24714411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralizing Antibodies Inhibit Chikungunya Virus Budding at the Plasma Membrane.
    Jin J; Galaz-Montoya JG; Sherman MB; Sun SY; Goldsmith CS; O'Toole ET; Ackerman L; Carlson LA; Weaver SC; Chiu W; Simmons G
    Cell Host Microbe; 2018 Sep; 24(3):417-428.e5. PubMed ID: 30146390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of neutralizing antibodies produced by papaya mosaic virus nanoparticles fused to the E2EP3 peptide epitope of Chikungunya envelope.
    Nor Rashid N; Teoh TC; Al-Harbi SJ; Yusof R; Rothan HA
    Trop Biomed; 2021 Mar; 38(1):36-41. PubMed ID: 33797522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of an infectious Chikungunya virus cDNA clone and stable insertion of mCherry reporter genes at two different sites.
    Kümmerer BM; Grywna K; Gläsker S; Wieseler J; Drosten C
    J Gen Virol; 2012 Sep; 93(Pt 9):1991-1995. PubMed ID: 22673932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate.
    Saraswat S; Athmaram TN; Parida M; Agarwal A; Saha A; Dash PK
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004782. PubMed ID: 27399001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A recombinant rabies virus expressing a phosphoprotein-eGFP fusion is rescued and applied to the rapid virus neutralization antibody assay.
    Tang HB; Lu ZL; Wei XK; Zhong YZ; Zhong TZ; Pan Y; Luo Y; Liao SH; Minamoto N; Luo TR
    J Virol Methods; 2015 Jul; 219():75-83. PubMed ID: 25845623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chikungunya Virus Fidelity Variants Exhibit Differential Attenuation and Population Diversity in Cell Culture and Adult Mice.
    Riemersma KK; Steiner C; Singapuri A; Coffey LL
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.